Skip to main content
. Author manuscript; available in PMC: 2017 Sep 26.
Published in final edited form as: Am J Surg Pathol. 2016 Dec;40(12):1679–1685. doi: 10.1097/PAS.0000000000000712

Table 5.

Microscopic characterization of lymphocytic esophagitis in patients with non-achalasia primary motility abnormalities and dysmotiltiy-negative gastroesophageal reflux disease.

Nutcracker
esophagus,
n=10, (%)
Ineffective
motility, n=7,
(%)
Diffuse spasm,
n=5,
(%)
All PEMD,
n=22,
(%)
DN-GERD,
n=4,
(%)
P-value
(all PEMD
versus
DN-GERD)
Lymphocytes, median (25th; 75th percentile) 65 (58; 150) 69 (75; 88) 67 (73; 142) 72 (63; 271) 67 (61; 88)
Distribution of increased IEL
  Focal 9 (90) 6 (86) 3 (60) 18 (82) 3 (75) 1.0
  Diffuse 1 (10) 1 (12) 2 (40) 4 (18) 1 (25) 1.0
Localization of increased IEL
  Peripapillary 9 (90) 4 (57) 3 (60) 15 (68) 2 (50) .59
  Peripapillary/interpapillary 1 (10) 3 (43) 2(40) 6 (27) 1 (25) 1.00
  Diffuse 0 0 0 1 (3) 1 (25) .29
Prominent spongiosis 3 (30) 2 (29) 2 (40) 7 (32) 0 .55
Cases with CD4-predominant IEL 5 (50) 6 (86) 3 (60) 14 (64) 1 (25) .28
Cases with CD8-predominant IEL 5 (50) 1 (14) 2 (40) 8 (36) 3(75) .28
CD4:CD8 ratio for CD4-predominant cases 1.7 ± 0.3 3.4 ± 2.1 3.0 ± 1.8 2.7 ± 1.7 2.1 -
CD4:CD8 ratio for CD8-predominant cases 0.5 ± 0.2 0.1 0.3 ± 0.1 0.4 ± 02 0.1 ± 0.1 .013

Abbreviations: IEL, intraepithelial lymphocytes; DN-GERD, dysmotility-negative gastroesophageal reflux disease; PEMD, non-achalasia primary motility disorders.